Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma × Disulfides × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 25 Ovarian Neoplasms 22 Fallopian Tube Neoplasms 20 Carcinoma, Non-Small-Cell Lung 20 Colorectal Neoplasms 14 Glioblastoma 9 Carcinoma, Renal Cell 9 Pancreatic Neoplasms 8 Melanoma 8 Squamous Cell Carcinoma of Head and Neck 7 Carcinoma, Hepatocellular 7 Brenner Tumor 7 Breast Neoplasms 7 Urinary Bladder Neoplasms 6 Mycosis Fungoides 6 Lymphoma, Large B-Cell, Diffuse 6 Prostatic Neoplasms 5 Lymphoma, T-Cell, Cutaneous 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Colonic Neoplasms 5 Brain Neoplasms 5 Triple Negative Breast Neoplasms 4 Sezary Syndrome 4 Sarcoma 4 Rectal Neoplasms 4 Neoplasm Metastasis 4 Multiple Myeloma 4 Uterine Cervical Neoplasms 3 Urethral Neoplasms 3 Ureteral Neoplasms 3

Interventions

Doxorubicin 22 Radiotherapy 12 Ifosfamide 11 Trabectedin 10 pazopanib 5 Gemcitabine 5 ribociclib 4 pembrolizumab 4 Specimen Handling 4 Docetaxel 4 Biopsy 4 selinexor 3 palbociclib 3 eribulin 3 X-Rays 3 Imatinib Mesylate 3 Filgrastim 3 Cyclophosphamide 3 temsirolimus 2 romidepsin 2 pegfilgrastim 2 liposomal doxorubicin 2 cixutumumab 2 brostallicin 2 brigimadlin 2 belinostat 2 avelumab 2 abemaciclib 2 Vincristine 2 Temozolomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04668300 2025-10-09

DOSa

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Hemangiosarcoma, Liposarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡